UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G/A
(Amendment No.)*3
Under the Securities Exchange Act of 1934
Palatin Technologies, Inc
Common Stock, par value $.01 per share
(Title of Class of Securities)
February 14, 2003
(CUSIP Number: 696077304)
December 31, 2002
Date of event which requires filing
Check the appropriate box to designate the rule pursuant to which the schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be filled for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act,
but shall be subject to all other provisions of the Act (however, see the Notes
to Schedule 13G).
1
--------------------------------------------------------------------------------
CUSIP No. 696077304 13G
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Lindsay A. Rosenwald, M.D.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 497,942
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 526,890
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 497,942
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH 526,890
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,024,832
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.6%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
2
ITEM 1(a). NAME OF ISSUER:
Palatin Technologies, Inc.
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
103 Carnegie Center, Suite 200
Princeton, NJ 08540
ITEM 2(a) NAME OF PERSON FILING:
Dr. Lindsay A. Rosenwald.
Dr. Rosenwald is an investment banker, venture capitalist, fund
manager and sole stockholder of Paramount Capital, a Subchapter S
corporation incorporated in Delaware. Paramount Capital is the
General Partner to Aries Domestic, a limited partnerships
incorporated in Delaware. Paramount Capital is the Investment
Manager to Aries Fund, a Cayman Islands exempted company.
Dr. Rosenwald, Paramount Capital, Aries Domestic, and Aries Fund and
their respective officers, directors, general partners, investment
managers, or trustees have not, during the five years prior to the
date hereof, been convicted in a criminal proceeding (excluding
traffic violations or similar misdemeanors).
ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
Dr. Rosenwald's business address is 787 Seventh Avenue, 48th Floor,
New York, New York, 10019.
ITEM 2(c). CITIZENSHIP:
Dr. Rosenwald is a citizen of the United States of America.
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock, par value $.01 per share.
ITEM 2(e). CUSIP NUMBER: 696077304
ITEM 3. |X| CHECK THIS BOX IF THIS STATEMENT IS FILED PURSUANT TO RULE
13d-1(c)
ITEM 4. OWNERSHIP
Dr. Rosenwald may be deemed the beneficial owner of the following number of
Shares:
Dr. Rosenwald may be deemed to own 591,515 Shares, which includes 233,270
shares owned by Paramount and 358,245 Shares owned by RAQ, LLC, for which
Dr. Rosenwlad is sole and managing member, and convertible securities to
purchase 433,317 Shares, which includes convertible securities to purchase
293,620 shares owned by Paramount. or approximately 3.6% of the Company's
outstanding Shares.
Dr. Rosenwald disclaims the beneficial ownership of the securities
beneficially owned by Paramount Capital except to the extent of his
pecuniary interest therein, if any.
3
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
None of the Reporting Persons own greater than 5% of any class of
securities of the Issuer.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
a transaction having that purpose and effect.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: February 14, 2003
New York, NY
By:/s/ Lindsay A. Rosenwald, M.D.
--------------------------------
Name: Lindsay A. Rosenwald, M.D.
4